Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Humanitarian Device Exemption Use Protocol of TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma

NCT00530010 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT00530010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00530010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Humanitarian Device Exemption Use Protocol of TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma
Lead sponsor
Northwestern University
Phase
Observational
Overall status
Completed
Start date
December 31, 2004
Completion date
March 8, 2022
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer